Categories Earnings, Health Care

Pfizer (PFE) reaffirms FY24 forecast; provides FY25 guidance

Pharmaceutical company Pfizer Inc. (NYSE: PFE) Tuesday reaffirmed its financial outlook for fiscal 2024 and provided guidance for fiscal 2025.

  • The company said it achieved the goal of $4 bln in cost savings through 2024 and anticipates an additional $500 mln in savings in 2025, from the ongoing cost realignment program
  • Pfizer continues to expect fiscal 2024 revenue in the range of $61 billion to $64 billion and confirmed its full-year adjusted EPS guidance of $2.75-2.95
  • For fiscal 2025, the management expects revenue to be in the range of $61 billion to $64 billion and adjusted EPS between $2.80 and $3.00
  • It is looking for adjusted EPS operational growth of 10-18% for FY25, from the midpoint of the 2024 guidance after adjusting for non-recurring items
  • Phase I of the company’s manufacturing optimization program is on track to deliver initial net cost savings in the latter part of 2025, towards the goal of improving gross margin performance
  • Adjusted SI&A expense is expected to be in the range of $13.3 to $14.3 billion in FY25, and adjusted R&D expenses between $10.7 billion and $11.7 billion

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Costco (COST) reports strong growth in Q1 FY26 earnings; revenue up 8%

Costco Wholesale Corporation (NASDAQ: COST) has reported an increase in net income for the first quarter of fiscal 2026. Revenues grew 8.3% year-over-year. The Issaquah, Washington-headquartered warehouse giant’s total revenues

AVGO Earnings: Broadcom reports higher Q4 FY25 revenue, profit; results beat

Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) on Thursday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. The numbers also surpassed analysts' expectations. Adjusted

Lamb Weston (LW) is set to report Q2 2026 earnings next week, here’s what to look for

Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose over 1% on Thursday. The stock has gained 4% over the past three months. The French fry giant is slated to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top